Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma

SIMPLE SUMMARY: Due to the complex mechanism of actions, immunomodulatory drugs (IMiDs) are one of the primary drug classes used to treat multiple myeloma (MM). IMiDs are the backbone of treatment for both newly diagnosed, post-transplant maintenance, and relapsed/refractory MM. The standard of care...

Descripción completa

Detalles Bibliográficos
Autores principales: Charliński, Grzegorz, Vesole, David H., Jurczyszyn, Artur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468542/
https://www.ncbi.nlm.nih.gov/pubmed/34572892
http://dx.doi.org/10.3390/cancers13184666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468542/
https://www.ncbi.nlm.nih.gov/pubmed/34572892
http://dx.doi.org/10.3390/cancers13184666

Ejemplares similares